Cellective Therapeutics
Gaithersburg, MD
Ticker: Nasdaq: MEDI
Cellective was a biopharmaceutical company focused on developing industry-leading therapeutic antibodies for the treatment of oncology and immune-related diseases. The company was acquired by MedImmune in 2005.